Philip Henry Sheridan is a Silver Spring, Maryland based neurologist who is specialized in Neurology. His current practice location is Fda Building 22 Rm 4372, 10903 New Hampshire Avenue, Silver Spring. Patients can reach him at 301-796-1145 or can fax him at 301-796-9842. Philip Henry Sheridan is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1578916516. Philip Henry Sheridan specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Philip Henry Sheridan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Philip Henry Sheridan
Specialization:
Neurology
Gender:
Male
Credentials:
M.D.
Practice Address:
Fda Building 22 Rm 4372, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993-0002
Phone:
301-796-1145
Fax:
301-796-9842
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1578916516
NPI Enumeration Date:
14 Jul, 2016
NPI Last Update On:
14 Jul, 2016
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Philip Henry Sheridan Fda Building 22 Rm 4372, 10903 New Hampshire Avenue Silver Spring, Maryland
Zip:
20993-0002
Phone Number:
301-796-1145
Fax Number:
301-796-9842
Patients can reach Philip Henry Sheridan at Fda Building 22 Rm 4372, 10903 New Hampshire Avenue, Silver Spring, Maryland or can call to book an appointment on 301-796-1145.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.